Argenx Se (ARGX) Research & Development (2016 - 2026)
Argenx Se's Research & Development came in at -$503 million for Q3 2026, compared with -$359 million a year earlier.
Powered by 
Analysis
Argenx Se (ARGX) Research & Development (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Argenx Se reported Research & Development of $54.29 million; for FY2025, it was $1.36 billion, up 38.7% from FY2024.
- Research & Development has increased in each of the last ten years, with a five-year compound annual growth rate of 29.8% (FY2020 to FY2025).
- Going back by year, Research & Development was $983.42 million in FY2024 (+14.4%), $859.49 million in FY2023 (+29.6%), $663.37 million in FY2022 (+14.3%) and $580.52 million in FY2021 (+56.5%).
- The Q3 2026 figure represents the lowest quarterly Research & Development in data going back to Q3 2016.
- Business Quant data shows ARGX's Research & Development at $1.37 billion (Q2 2026), -$443 million (Q1 2026) and -$371.71 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Argenx Se | 56.96 Bn | 56.96 Bn | 1.56 Bn | 503.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 503.00 Mn |
| Jun 30, 2026 | 486.00 Mn |
| Mar 31, 2026 | 443.00 Mn |
| Dec 31, 2025 | 371.71 Mn |
| Sep 30, 2025 | 359.00 Mn |
| Jun 30, 2025 | 327.70 Mn |
| Mar 31, 2025 | 311.00 Mn |
| Dec 31, 2024 | 297.23 Mn |
| Sep 30, 2024 | 235.94 Mn |
| Jun 30, 2024 | 225.29 Mn |
| Mar 31, 2024 | 224.97 Mn |
| Dec 31, 2023 | 306.37 Mn |
| Sep 30, 2023 | 191.76 Mn |
| Jun 30, 2023 | 195.51 Mn |
| Mar 31, 2023 | 165.86 Mn |
| Dec 31, 2022 | 147.80 Mn |
| Sep 30, 2022 | 236.68 Mn |
| Jun 30, 2022 | 126.92 Mn |
| Mar 31, 2022 | 151.97 Mn |
| Dec 31, 2021 | 167.17 Mn |
API Access
Argenx Se Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ARGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ARGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ARGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();